Logo of bmcidBioMed Central web sitethis articleSearchManuscript submissionRegistrationJournal front page
PMC full text:

Table 1

Baseline characteristics of the patients

VariablesNo-CC groupCC groupP value
N = 49N = 71
Sex, N (%)0.856
 Male35 (71.4)53 (74.6)
 Female14 (28.6)18 (25.4)
Age, years old40. 4 (8. 5)34.7 (5.8)< 0.001

Alanine aminotransferase, U/L

(Normal range 9–50 U/L)

31.0 (27.0, 37.0)37.7 (23.5, 61.0)0.068

Aspartate aminotransferase, U/L

(Normal range 15–40 U/L)

31.0 (26.0, 37.0)30.0 (22.5, 45.4)0.685
HBsAg, IU/ml621.6 (258.0, 1658.0)25.8 (4.0, 189.6)< 0.001
HBeAg, IU/ml0.5 (0.4, 0.8)0.38 (0.3, 0.5)0.02
HBeAb, IU/ml0.005 (0.004, 0.006)0.004 (0.003–0.005)0.070
White blood cell, 109/L5.4 (1. 6)5.2 (1.6)0.414
Platelet, 1012/L196.5 (59.2)179.5 (64.2)0.145
Neutrophils, 109/L2.8 (1.1)2.7 (1.1)0.401
Lymphocyte, 109/L2.1 (0.7)1.9 (0.5)0.035

AFP

(Normal range 0–7.0 ng/ml)

5.6 (11.9)3.1 (2.5)0.092
Liver ultrasound scores, N (%)0.035
 042 (85.7)47 (66.2)
 16 (12.2)15 (21.1)
 21 (2.0)9 (12.7)

Abbreviation: CC = clinical cure; HBsAg = Hepatitis B surface antigen

Categorical variables were expressed as percentages. Group comparisons used the chi-square test. Mean ± standard deviation described normal distribution data, analyzed with the t-test, while skewed distribution data used the median (interquartile range) with non-parametric testing